Helus Pharma, Inc. (HELP)
10.71
-0.20
(-1.83%)
USD |
NASDAQ |
Oct 29, 16:00
10.60
-0.11
(-1.03%)
After-Hours: 18:58
Helus Pharma Price to Book Value : 2.742 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 2.793 |
| October 27, 2026 | 2.694 |
| October 26, 2026 | 2.653 |
| October 23, 2026 | 2.609 |
| October 22, 2026 | 2.688 |
| October 21, 2026 | 2.760 |
| October 20, 2026 | 2.801 |
| October 19, 2026 | 2.737 |
| October 16, 2026 | 2.701 |
| October 15, 2026 | 2.829 |
| October 14, 2026 | 2.658 |
| October 13, 2026 | 2.688 |
| October 12, 2026 | 2.824 |
| October 09, 2026 | 3.021 |
| October 08, 2026 | 2.745 |
| October 07, 2026 | 2.691 |
| October 06, 2026 | 2.755 |
| October 05, 2026 | 2.924 |
| October 02, 2026 | 2.996 |
| October 01, 2026 | 3.049 |
| September 30, 2026 | 3.147 |
| September 29, 2026 | 3.252 |
| September 28, 2026 | 3.224 |
| September 25, 2026 | 3.229 |
| September 24, 2026 | 3.224 |
| Date | Value |
|---|---|
| September 23, 2026 | 3.334 |
| September 22, 2026 | 3.510 |
| September 21, 2026 | 3.498 |
| September 18, 2026 | 3.167 |
| September 17, 2026 | 3.590 |
| September 16, 2026 | 3.449 |
| September 15, 2026 | 3.359 |
| September 14, 2026 | 3.485 |
| September 11, 2026 | 3.321 |
| September 10, 2026 | 3.288 |
| September 09, 2026 | 3.503 |
| September 08, 2026 | 3.172 |
| September 04, 2026 | 3.129 |
| September 03, 2026 | 3.014 |
| September 02, 2026 | 3.060 |
| September 01, 2026 | 2.970 |
| August 31, 2026 | 3.011 |
| August 28, 2026 | 3.119 |
| August 27, 2026 | 3.39 |
| August 26, 2026 | 3.490 |
| August 25, 2026 | 3.581 |
| August 24, 2026 | 3.334 |
| August 21, 2026 | 3.224 |
| August 20, 2026 | 3.193 |
| August 19, 2026 | 3.016 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 8.096 |
| NervGen Pharma Corp. | 4.674 |
| Milestone Pharmaceuticals, Inc. | 5.341 |
| Appili Therapeutics, Inc. | -- |
| Clearmind Medicine, Inc. | 0.1220 |
Price to Book Value Related Metrics
| Price | 10.71 |
| Earnings Yield | -39.64% |
| Market Cap | 663.85M |